| Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract MC Lane, CJ Alteri, SN Smith, HLT Mobley Proceedings of the National Academy of Sciences 104 (42), 16669-16674, 2007 | 468 | 2007 |
| Fitness of Escherichia coli during urinary tract infection requires gluconeogenesis and the TCA cycle CJ Alteri, SN Smith, HLT Mobley PLoS pathogens 5 (5), e1000448, 2009 | 319 | 2009 |
| Mycobacterium tuberculosis produces pili during human infection CJ Alteri, J Xicohténcatl-Cortes, S Hess, G Caballero-Olín, JA Girón, ... Proceedings of the National Academy of Sciences 104 (12), 5145-5150, 2007 | 250 | 2007 |
| Mucosal immunization with iron receptor antigens protects against urinary tract infection CJ Alteri, EC Hagan, KE Sivick, SN Smith, HLT Mobley PLoS pathogens 5 (9), e1000586, 2009 | 208 | 2009 |
| Escherichia coli physiology and metabolism dictates adaptation to diverse host microenvironments CJ Alteri, HLT Mobley Current opinion in microbiology 15 (1), 3-9, 2012 | 179 | 2012 |
| Quantitative profile of the uropathogenic Escherichia coli outer membrane proteome during growth in human urine CJ Alteri, HLT Mobley Infection and immunity 75 (6), 2679-2688, 2007 | 155 | 2007 |
| Multicellular bacteria deploy the type VI secretion system to preemptively strike neighboring cells CJ Alteri, SD Himpsl, SR Pickens, JR Lindner, JS Zora, JE Miller, PD Arno, ... PLoS pathogens 9 (9), e1003608, 2013 | 139 | 2013 |
| FdeC, a novel broadly conserved Escherichia coli adhesin eliciting protection against urinary tract infections B Nesta, G Spraggon, C Alteri, DG Moriel, R Rosini, D Veggi, S Smith, ... MBio 3 (2), e00010-12, 2012 | 117 | 2012 |
| Dietary l-serine confers a competitive fitness advantage to Enterobacteriaceae in the inflamed gut S Kitamoto, CJ Alteri, M Rodrigues, H Nagao-Kitamoto, K Sugihara, ... Nature microbiology 5 (1), 116-125, 2020 | 107 | 2020 |
| Preferential use of central metabolism in vivo reveals a nutritional basis for polymicrobial infection CJ Alteri, SD Himpsl, HLT Mobley PLoS pathogens 11 (1), e1004601, 2015 | 98 | 2015 |
| Prophage induction is enhanced and required for renal disease and lethality in an EHEC mouse model JS Tyler, K Beeri, JL Reynolds, CJ Alteri, KG Skinner, JH Friedman, ... PLoS pathogens 9 (3), e1003236, 2013 | 94 | 2013 |
| The Versatile Type VI Secretion System CJ Alteri, HLT Mobley Microbiology spectrum 4 (2), 2016 | 86 | 2016 |
| Metabolism and Fitness of Urinary Tract Pathogens. CJ Alteri, HL Mobley Microbiology spectrum 3 (3), 2015 | 84 | 2015 |
| The broadly conserved regulator PhoP links pathogen virulence and membrane potential in Escherichia coli CJ Alteri, JR Lindner, DJ Reiss, SN Smith, HLT Mobley Molecular microbiology 82 (1), 145-163, 2011 | 84 | 2011 |
| Development of a vaccine against Escherichia coli urinary tract infections HLT Mobley, CJ Alteri Pathogens 5 (1), 1, 2016 | 66 | 2016 |
| SslE Elicits Functional Antibodies That Impair In Vitro Mucinase Activity and In Vivo Colonization by Both Intestinal and Extraintestinal Escherichia coli Strains B Nesta, M Valeri, A Spagnuolo, R Rosini, M Mora, P Donato, CJ Alteri, ... PLoS pathogens 10 (5), e1004124, 2014 | 64 | 2014 |
| Identification of in vivo-induced antigens including an RTX family exoprotein required for uropathogenic Escherichia coli virulence PD Vigil, CJ Alteri, HLT Mobley Infection and immunity 79 (6), 2335-2344, 2011 | 60 | 2011 |
| Anaerobic respiration using a complete oxidative TCA cycle drives multicellular swarming in Proteus mirabilis CJ Alteri, SD Himpsl, MD Engstrom, HLT Mobley Mbio 3 (6), e00365-12, 2012 | 43 | 2012 |
| Optimization of an Experimental Vaccine to Prevent Escherichia coli Urinary Tract Infection VS Forsyth, SD Himpsl, SN Smith, CA Sarkissian, LA Mike, JA Stocki, ... mBio 11 (2), 2020 | 40 | 2020 |
| Subtle variation within conserved effector operon gene products contributes to T6SS-mediated killing and immunity CJ Alteri, SD Himpsl, K Zhu, HL Hershey, N Musili, JE Miller, HLT Mobley PLoS pathogens 13 (11), e1006729, 2017 | 32 | 2017 |
